Compare AURA & SWIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AURA | SWIM |
|---|---|---|
| Founded | 2007 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Plastic Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 713.4M | 657.5M |
| IPO Year | 2021 | 2021 |
| Metric | AURA | SWIM |
|---|---|---|
| Price | $7.60 | $6.10 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 4 |
| Target Price | ★ $20.00 | $6.75 |
| AVG Volume (30 Days) | 661.7K | ★ 881.5K |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 160.00 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $545,912,000.00 |
| Revenue This Year | N/A | $10.95 |
| Revenue Next Year | N/A | $6.34 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.35 |
| 52 Week Low | $4.73 | $4.64 |
| 52 Week High | $9.54 | $8.97 |
| Indicator | AURA | SWIM |
|---|---|---|
| Relative Strength Index (RSI) | 63.14 | 58.01 |
| Support Level | $5.18 | $5.07 |
| Resistance Level | $7.81 | $6.81 |
| Average True Range (ATR) | 0.50 | 0.27 |
| MACD | 0.12 | 0.06 |
| Stochastic Oscillator | 99.37 | 56.49 |
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
Latham Group Inc is a designer, manufacturer, and marketer of in-ground residential swimming pools, liners, and covers in North America, Australia, and New Zealand. The company derives a majority of its revenue from the United States.